Results 11 to 20 of about 69,560 (333)

Thymoma with Autoimmune Hemolytic Anemia

Case Reports in Oncology, 2014
A 38-year-old Japanese male was referred to our hospital with abnormal chest X-ray results and severe Coombs-positive hemolytic anemia. He was diagnosed with a stage IV, WHO type A thymoma and was treated with oral prednisolone (1 mg/kg/day) and ...
Kensuke Suzuki, Minehiko Inomata, Shiori Shiraishi, Ryuji Hayashi, Kazuyuki Tobe   +4 more
doaj   +3 more sources

Mixed Autoimmune Hemolytic Anemia: A Systematic Review of Epidemiology, Clinical Characteristics, Therapies, and Outcomes. [PDF]

Am J Hematol
Jacobs JW, Raza S, Clark LM, Stephens LD, Allen ES, Woo JS, Walden RL, Figueroa Villalba CA, Tormey CA, Stanek CG, Adkins BD, Bloch EM, Booth GS.   +12 more
europepmc   +3 more sources

Pancytopenia with autoimmune hemolytic anemia

Apollo Medicine, 2021
Payal Bargujar, Hemant Bagra, Hans Raj Pahadiya   +2 more
doaj   +2 more sources

Autoimmune hemolytic anemia [PDF]

Vnitřní lékařství, 2018
Autoimmune hemolytic anemia (AIHA) is caused by auto-antibodies directed against self red blood cell (RBC) surface antigens. A consequence may be an intravascular hemolysis mediated by activated complement or extravascular hemolysis caused by destruction of complex of RBC with autoantibody in spleen and liver.
Jaroslav, Čermák, Martin, Písačka
openaire   +5 more sources

The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?

Frontiers in Immunology, 2023
Autoimmune hemolytic anemia (AIHA) is defined by increased erythrocyte turnover mediated by autoimmune mechanisms. While corticosteroids remain first-line therapy in most cases of warm-antibody AIHA, cold agglutinin disease is treated by targeting the ...
S. Berentsen, B. Fattizzo, W. Barcellini
semanticscholar   +1 more source

Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gaps

Frontiers in Immunology, 2023
Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disorder, mediated by auto-antibodies, and has a variable clinical course ranging from fully compensated low grade hemolysis to severe life-threatening cases.
Femke V. M. Mulder, D. Evers, Masja de Haas, M. J. Cruijsen, Sophie J. Bernelot Moens, W. Barcellini, B. Fattizzo, Josephine M I Vos   +7 more
semanticscholar   +1 more source

Acute Tubular Necrosis Associated with Autoimmune Hemolytic Anemia due to Acute Gastroenteritis

Turkish Journal of Internal Medicine, 2021
Autoimmune hemolytic anemia (AIHA) is a rare disease with a rate of 1-3 in 100,000 in adults. AIHA are defined as primary (idiopathic) or secondary depending on the presence or absence of accompanying disease.
Mehmet Sezen, Abdülmecit Yıldız, Mahmut Yavuz, Kamil Dilek, Mustafa Güllülü, Ayşegül Oruç, Mehmet Fethullah Aydın, Alparslan Ersoy   +7 more
doaj   +1 more source

Autoimmune hemolytic anemia: causes and consequences

Expert Review of Clinical Immunology, 2022
Introduction Autoimmune hemolytic anemia (AIHA) is classified according to the direct antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold forms, and in primary versus secondary depending on the presence of ...
B. Fattizzo, W. Barcellini
semanticscholar   +1 more source

Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia

Journal of Thrombosis and Haemostasis, 2022
Thrombosis may complicate autoimmune hemolytic anemia (AIHA), but its predictors are still lacking, and no clear‐cut indications for anticoagulant prophylaxis are available.
B. Fattizzo, M. Bortolotti, J. Giannotta, A. Zaninoni, D. Consonni, W. Barcellini   +5 more
semanticscholar   +1 more source

Systemic Lupus Erythematosus With Catastrophic APS and Libman-Sacks Endocarditis in a Patient With Autoimmune Hemolytic Anemia: A Case Report. [PDF]

Clin Case Rep
ABSTRACT Systemic lupus erythematosus (SLE) can lead to antiphospholipid syndrome (APS) and catastrophic APS (CAPS), causing severe thrombotic events. This case of autoimmune hemolytic anemia (AIHA) with stroke and Libman–Sacks endocarditis highlights the need for APS evaluation and shows that prompt anticoagulation and immunosuppressive therapy are ...
Ehsan S, Afshar S, Bakhtiari S, Pourfallah R, Danaei Mehrabad S.   +4 more
europepmc   +2 more sources